Samsung Biologics Q2 Operating Profit 166.7 Billion KRW... Up 105.62% YoY

Samsung Biologics announced on the 27th that its preliminary consolidated results for the second quarter recorded sales of 412.163 billion KRW and an operating profit of 166.76 billion KRW. This represents an increase of 33.95% in sales and 105.62% in operating profit compared to the same period last year.